Johns Hopkins Medicine: Liquid Biopsy Predicts Early Disease Progression, Potential Survival in Patients With Advanced Breast Cancer
June 14, 2023
June 14, 2023
BALTIMORE, Maryland, June 14 (TNSjou) -- Johns Hopkins Medicine issued the following news release:
A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict early disease progression and potential survival among patients with metastatic breast cancer in as little as one month after starting treatment, according to a recent study.
The test -- so far, a prototype for research use only -- was able t . . .
A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict early disease progression and potential survival among patients with metastatic breast cancer in as little as one month after starting treatment, according to a recent study.
The test -- so far, a prototype for research use only -- was able t . . .